News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Japan Approves AstraZeneca PLC’s (JOBS) Symbicort
October 16, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
AP -- Drugmaker AstraZeneca PLC said Friday that its Symbicort inhaler has been approved in Japan for use as a treatment for asthma in adults.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
AstraZeneca
MORE ON THIS TOPIC
Manufacturing
FDA pilots AI-informed one-day facility inspections
May 7, 2026
·
2 min read
·
Nick Paul Taylor
FDA
FDA reverses course on Atara, Pierre Fabre’s twice-rejected cell therapy after Prasad’s exit
May 7, 2026
·
3 min read
·
Heather McKenzie
FDA
Sanofi requests removal of Tzield from CNPV program after Høeg gets involved
May 7, 2026
·
4 min read
·
Heather McKenzie
Policy
Makary defends Replimune melanoma rejection again as FDA tensions build
May 6, 2026
·
3 min read
·
Tristan Manalac
